Approvals/TGA/CSL New Zealand Rh(D) Immunoglobulin-VF (Human Anti-D Rho Immunoglobulin), 625IU, solution for injection, vial

Approved

STANDARD

CSL New Zealand Rh(D) Immunoglobulin-VF (Human Anti-D Rho Immunoglobulin), 625IU, solution for injection, vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4c5321f0668dce4c
Product Name: CSL New Zealand Rh(D) Immunoglobulin-VF (Human Anti-D Rho Immunoglobulin), 625IU, solution for injection, vial
Artg Id: 391433
Artg Name: CSL New Zealand Rh(D) Immunoglobulin-VF (Human Anti-D Rho Immunoglobulin), 625IU, solution for injection, vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2022-06-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

4c5321f0668dce4c

Type

Standard